A small but clinically important subset of HIV patients—approximately 3 percent—experience detectable viral traces despite strict treatment adherence, a phenomenon that has puzzled clinicians for years. New research now provides clarity on this mystery: most persistent detections consist of defective HIV copies incapable of replication, not infectious virus. The study employed sophisticated molecular analysis to distinguish between viral particle types in patient blood samples, revealing that current monitoring practices may overestimate the clinical significance of low-level detections. This distinction is crucial because it separates true treatment failure from harmless residual viral material. Understanding this difference could reduce patient anxiety and prevent unnecessary treatment modifications for individuals whose therapy remains genuinely effective. Read the full article on GMJ Newsroom.
Was this article helpful?
